Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Nemaura Medical Inc NMRD

Healthcare Medical Devices
Nemaura Medical Inc., through its operating subsidiaries, performs medical device research and manufacturing of a continuous glucose monitoring system (CGM), named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and may also be used to screen pre-diabetic patients and support obesity and weight-loss programs. The sugarBEAT... see more

Current News (GREY:NMRD)

Important Update on Listing Status and Strategic Direction

GlobeNewswire January 3, 2024

Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision

GlobeNewswire December 13, 2023

Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth

GlobeNewswire November 21, 2023

Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs

GlobeNewswire November 14, 2023

Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update

GlobeNewswire November 13, 2023

Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.

GlobeNewswire September 26, 2023

Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference

GlobeNewswire September 18, 2023

Nemaura Medical Provides Update on Nasdaq Compliance Status and Process

GlobeNewswire September 14, 2023

Nemaura Medical Announces Interim Results from its Collaboration with the UK's National Health Service on its Metabolic Health & Weight Loss Program

GlobeNewswire September 13, 2023
View More News ››

Opinion & Analysis (GREY:NMRD)

Nemaura Medical Accelerates Launch of sugarBEAT Wearable Continuous Glucose Monitor

Streetwise Reports February 27, 2020
View More Opinion ››

Bullboard Posts (GREY:NMRD)

At DTL now....

Be careful here  Geez ... I'm haddicapping a deal I have no position in  I must be off my rocker ????
Iseneschal - May 5, 2021

Yep....sure wood

Huge spike after unhalted
Iseneschal - May 5, 2021

Halted at 22 after....

should be back and .... I would say another pop Cheers 
Iseneschal - May 5, 2021

Huge green spike

just sayin
Iseneschal - May 5, 2021

RE:RE:Whoap dare id is !!!!!!!!!!!!!!!!

I hate it when I'm right..... And I don't have an effing position ! Dang !!!!!!!
Iseneschal - May 5, 2021

RE:Twin Towers of Volume....

Weeeeeellllllllll....Looks like that ain't going to happen Sheesh
Iseneschal - May 5, 2021
View more Bullboard ››

Mink Ventures Corp.

Mink Ventures Corp.

Mink Ventures Corporation is a Canadian mineral exploration company exploring critical minerals in Ontario, Canada. The ...
View More »